- Home
- PMVP vs GNTA Comparison
PMVP vs GNTA Comparison
Compare PMVP & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- GNTA
- Stock Information
- Founded
- PMVP 2013
- GNTA 2014
- Country
- PMVP United States
- GNTA Italy
- Employees
- PMVP N/A
- GNTA N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMVP Health Care
- GNTA Health Care
- Exchange
- PMVP Nasdaq
- GNTA Nasdaq
- Market Cap
- PMVP 62.3M
- GNTA 81.2M
- IPO Year
- PMVP 2020
- GNTA 2021
- Fundamental
- Price
- PMVP $1.35
- GNTA $3.74
- Analyst Decision
- PMVP Strong Buy
- GNTA Strong Buy
- Analyst Count
- PMVP 1
- GNTA 1
- Target Price
- PMVP $5.00
- GNTA $25.00
- AVG Volume (30 Days)
- PMVP 245.8K
- GNTA 27.5K
- Earning Date
- PMVP 08-07-2025
- GNTA 01-01-0001
- Dividend Yield
- PMVP N/A
- GNTA N/A
- EPS Growth
- PMVP N/A
- GNTA N/A
- EPS
- PMVP N/A
- GNTA N/A
- Revenue
- PMVP N/A
- GNTA N/A
- Revenue This Year
- PMVP N/A
- GNTA N/A
- Revenue Next Year
- PMVP N/A
- GNTA N/A
- P/E Ratio
- PMVP N/A
- GNTA N/A
- Revenue Growth
- PMVP N/A
- GNTA N/A
- 52 Week Low
- PMVP $0.81
- GNTA $2.74
- 52 Week High
- PMVP $1.82
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- PMVP 63.34
- GNTA 48.86
- Support Level
- PMVP $1.29
- GNTA $3.51
- Resistance Level
- PMVP $1.39
- GNTA $3.89
- Average True Range (ATR)
- PMVP 0.08
- GNTA 0.32
- MACD
- PMVP 0.01
- GNTA 0.03
- Stochastic Oscillator
- PMVP 78.87
- GNTA 77.78
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.